Publication: Tuberculosis and Non-Tuberculous Mycobacterial Infection: Drug Resistance Mechanisms and Development of Novel Therapy
Tuberculosis and Non-Tuberculous Mycobacterial Infection: Drug Resistance Mechanisms and Development of Novel Therapy
Date
Date
Date
Citations
Griesser, T. (2025). Tuberculosis and Non-Tuberculous Mycobacterial Infection: Drug Resistance Mechanisms and Development of Novel Therapy. (Dissertation, University of Zurich) https://doi.org/10.5167/uzh-276564
Abstract
Abstract
Abstract
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, is one of the most success-ful pathogens on Earth. Annually, 10 million individuals are newly infected, with the disease re-sponsible for approximately 1.5 million deaths. The treatment of drug-susceptible tuberculosis comprises of four first-line drugs: rifampicin, isoniazid, pyrazinamide and ethambutol. The afore-mentioned four drugs will be administered for a period of two months, after which a four-month continuation phase will commence, during which rifampicin
Metrics
Views
Citations
Additional indexing
Creators (Authors)
Faculty
Faculty
Faculty
Item Type
Item Type
Item Type
Referees
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Place of Publication
Place of Publication
Place of Publication
Publication date
Publication date
Publication date
Date available
Date available
Date available
Number of pages
Number of pages
Number of pages
OA Status
OA Status
OA Status
Metrics
Views
Citations
Citations
Griesser, T. (2025). Tuberculosis and Non-Tuberculous Mycobacterial Infection: Drug Resistance Mechanisms and Development of Novel Therapy. (Dissertation, University of Zurich) https://doi.org/10.5167/uzh-276564
